Skip to main content

Table 1 Clinical and demographic profile of patents, including time from onset, 7–14 day follow-up and final follow-up for each of the groups

From: Visual outcome of various dose of glucocorticoids treatment in nonarteritic anterior ischemic optic neuropathy– a retrospective analysis

 

Total

Groups

P value

Group1

Group2

Group3

Group4

Age (yrs), mean ± SD

56.4 ± 9.7

56.5 ± 11.7

58.8 ± 8.2

57.9 ± 8.5

53.0 ± 10.2

0.203#

Gender (male:female)

29/53

4/11

5/9

12/18

8/15

0.836$

Time from onset, median (range day)

10

(7.0–14.0)

10

(7.0–14.0)

12.5

(7.0–14.0)

10

(7.0–10.0)

10

(9.3–14.0)

0.335*

Short-term follow-up (day)

9

(7.0–11.0)

14

(7.0–14.0)

8

(7.0–11.8)

8

(7.0–9.0)

9

(7.0–11.0)

0.102*

Final follow-up (day)

43

(14.5-214.5)

41

(14.0-208.0)

25.5

(14.8–623.0)

27

(13.0-149.5)

60

(22.8–318.0)

0.252*

  1. #Based on Chi-Square test
  2. $Based on ANOVA
  3. *Based on Kruskal-Walls test